A detailed history of Cambridge Advisors Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cambridge Advisors Inc. holds 10,075 shares of NVS stock, worth $990,876. This represents 0.26% of its overall portfolio holdings.

Number of Shares
10,075
Previous 10,075 -0.0%
Holding current value
$990,876
Previous $1.07 Million 8.02%
% of portfolio
0.26%
Previous 0.26%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$95.27 - $108.47 $66,689 - $75,929
-700 Reduced 6.5%
10,075 $974,000
Q2 2023

Jul 13, 2023

SELL
$92.52 - $104.91 $85,581 - $97,041
-925 Reduced 7.91%
10,775 $1.09 Million
Q1 2023

Apr 13, 2023

SELL
$80.03 - $92.81 $4,001 - $4,640
-50 Reduced 0.43%
11,700 $1.08 Million
Q3 2022

Oct 17, 2022

SELL
$74.61 - $87.26 $113,780 - $133,071
-1,525 Reduced 11.49%
11,750 $893,000
Q2 2022

Jul 18, 2022

SELL
$80.52 - $93.75 $80,520 - $93,750
-1,000 Reduced 7.01%
13,275 $1.12 Million
Q1 2022

May 05, 2022

SELL
$80.11 - $90.62 $8,011 - $9,062
-100 Reduced 0.7%
14,275 $1.25 Million
Q4 2021

Jan 14, 2022

SELL
$79.7 - $88.13 $31,880 - $35,252
-400 Reduced 2.71%
14,375 $1.26 Million
Q3 2021

Oct 19, 2021

SELL
$81.78 - $95.14 $4,089 - $4,757
-50 Reduced 0.34%
14,775 $1.21 Million
Q2 2021

Jul 21, 2021

SELL
$85.24 - $94.15 $8,524 - $9,415
-100 Reduced 0.67%
14,825 $1.35 Million
Q2 2019

Jul 26, 2019

SELL
$75.4 - $92.8 $143,260 - $176,320
-1,900 Reduced 11.29%
14,925 $1.36 Million
Q1 2019

Apr 16, 2019

SELL
$75.32 - $86.15 $94,074 - $107,601
-1,249 Reduced 6.91%
16,825 $1.62 Million
Q3 2018

Oct 24, 2018

SELL
$66.94 - $77.43 $15,061 - $17,421
-225 Reduced 1.23%
18,074 $1.56 Million
Q1 2018

Apr 18, 2018

BUY
$70.39 - $84.15 $10,558 - $12,622
150 Added 0.83%
18,299 $1.48 Million
Q4 2017

Jan 26, 2018

SELL
$72.33 - $77.64 $18,154 - $19,487
-251 Reduced 1.36%
18,149 $1.52 Million
Q3 2017

Oct 27, 2017

BUY
$74.14 - $77.27 $1.36 Million - $1.42 Million
18,400
18,400 $1.58 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cambridge Advisors Inc. Portfolio

Follow Cambridge Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.